Evelo Biosciences, Inc. Annual Nonoperating Income (Expense) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Evelo Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2022.
  • Evelo Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$1.2M, a 14.6% increase year-over-year.
  • Evelo Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$4.7M, a 11.5% decline year-over-year.
  • Evelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was -$5.13M, a 19.2% increase from 2021.
  • Evelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$6.35M, a 363% decline from 2020.
  • Evelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.37M, a 228% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$5.13M +$1.22M +19.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 -$6.35M -$4.98M -363% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$1.37M -$2.45M -228% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $1.08M -$82K -7.09% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $1.16M +$1.67M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 -$516K -$209K -68.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 -$307K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.